The company offers a range of vitamin ingredients in various forms and concentrations to nutritional supplement consumer companies, digitally native brands, and distributors worldwide. Kappa Bioscience's patented DELTA microencapsulation process provides K2 stability in mineral formulations, making K2VITAL an ideal ingredient for brands and manufacturers to reach broader market segments. Kappa Ingredients GmbH, a wholly-owned division of Kappa Bioscience, manages global sales of K2VITAL and other product lines related to bones, joints, and cardiovascular health. The company believes in building strong, lasting partnerships with like-minded partners who share their passion for vitamin K2 and their vision to change the industry by doing things differently. Kappa Bioscience is headquartered in Oslo, Norway, and has been a company of Balchem Corporation since 2022.